Company Pivotal Therapeutics Inc. Other OTC
Equities
PVTTF
CA72582E1043
Pharmaceuticals
Business Summary
Sales per Business
USD in Million | 2013 | Weight | 2014 | Weight | Delta |
---|---|---|---|---|---|
Omega-3 Pharmaceutical Products
100.0
%
| 0 | 100.0 % | 0 | 100.0 % | -5.76% |
Sales per region
USD in Million | 2013 | Weight | 2014 | Weight | Delta |
---|---|---|---|---|---|
United States
99.2
%
| 0 | 97.2 % | 0 | 99.2 % | -3.83% |
Canada
0.8
%
| 0 | 2.8 % | 0 | 0.8 % | -74.01% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Founder | - | 10-09-30 | |
George Jackowski
FOU | Founder | - | 10-09-30 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
George Jackowski
FOU | Founder | - | 10-09-30 |
John Gebhardt
CHM | Chairman | 77 | 11-11-21 |
Founder | - | 10-09-30 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 96,566,669 | 96,566,669 ( 100.00 %) | 0 | 100.00 % |
Company contact information
Pivotal Therapeutics, Inc.
30 Pennsylvania Avenue Unit 17
L4K 4A5, Concord
+
http://www.pivotaltherapeutics.usSector
Sales per region
1st Jan change | Capi. | |
---|---|---|
+20.08% | 22.46B | |
+18.55% | 15.04B | |
+18.94% | 13.98B | |
+56.80% | 13.15B | |
-10.55% | 6.89B | |
-0.05% | 6.79B | |
-8.87% | 5.73B | |
+14.03% | 5.71B | |
+6.11% | 4.69B |